Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE

Description

The present invention relates to the treatment of dementia and neurodegenerative diseases like Alzheimer's disease with intermediate doses of LHRH antagonists which do not cause a castration. A preferred LHRH antagonist is cetrorelix.

Resources

Name Format Description Link
21 Access the complete Patent AT-E400287-T1: [Translated] LOW DOSE LHRH ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, IN PARTICULAR ALZHEIMER'S DISEASE on the official website. https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400287-T1

Tags

  • patent
  • chemistry
  • research
  • innovation
  • pubchem

Topics

Categories